Labetalol 5 Mg/Ml Rbc 5 mg Injection
PDF Leaflet Revision Date: 30 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Severe hypertension and controlled hypotension during anaesthesia.
Dosage (summary)
IV bolus: 50 mg, max 200 mg; infusion: 2 mg/min until response.
Onset of Action / Duration
Onset: 5 mins, Duration: 6-18 hours
Special Populations
- Hepatic impairment
- Renal impairment
- Pregnancy
Pregnancy & Breastfeeding
Use with caution; may affect fetus and is contraindicated in breastfeeding.
Key Drug Interactions
- Calcium antagonists
- Clonidine
- Insulin
Contraindications
- Hypersensitivity
- Asthma
- Heart block
- Uncontrolled heart failure
Common side effects
- Postural hypotension
- Bradycardia
- Rash
- Nausea
Counselling Points
- Monitor blood pressure and heart rate
- Avoid sudden position changes
- Report any rash or breathing issues
Serious warnings
- Severe hepatotoxicity
- Risk of bradycardia
- Caution in heart failure
Important Disclaimer
The Labetalol 5 Mg/Ml Rbc 5 mg Injection professional information leaflet below is the property of Rbc Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
